Nicolas Jacques

Liege, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Ticagrelor alters the membrane of Staphylococcus aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance.

Ticagrelor alters the membrane of Staphylococcus aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance.

Journal: mBio

Published: September 23, 2024

The Spx stress regulator confers high-level β-lactam resistance and decreases susceptibility to last-line antibiotics in methicillin-resistant Staphylococcus aureus.

The Spx stress regulator confers high-level β-lactam resistance and decreases susceptibility to last-line antibiotics in methicillin-resistant Staphylococcus aureus.

Journal: Antimicrobial agents and chemotherapy

Published: May 01, 2024

A Clinically Selected Staphylococcus aureus clpP Mutant Survives Daptomycin Treatment by Reducing Binding of the Antibiotic and Adapting a Rod-Shaped Morphology.

A Clinically Selected Staphylococcus aureus clpP Mutant Survives Daptomycin Treatment by Reducing Binding of the Antibiotic and Adapting a Rod-Shaped Morphology.

Journal: Antimicrobial agents and chemotherapy

Published: May 15, 2023

Bioactive surface coating for preventing mechanical heart valve thrombosis.

Bioactive surface coating for preventing mechanical heart valve thrombosis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 12, 2023

Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent Staphylococcus aureus in Mice.

Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent Staphylococcus aureus in Mice.

Journal: JACC. Basic to translational science

Published: December 06, 2022

Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?

Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?

Journal: Frontiers in cell and developmental biology

Published: May 28, 2021

Synthesis of ticagrelor analogues belonging to 1,2,3-triazolo[4,5-d]pyrimidines and study of their antiplatelet and antibacterial activity.

Synthesis of ticagrelor analogues belonging to 1,2,3-triazolo[4,5-d]pyrimidines and study of their antiplatelet and antibacterial activity.

Journal: European journal of medicinal chemistry

Published: May 27, 2020

Tackling prosthetic heart valve-related deterioration: Liège translational cardiovascular research programme.

Tackling prosthetic heart valve-related deterioration: Liège translational cardiovascular research programme.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: April 18, 2020

Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.

Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.

Journal: JAMA cardiology

Published: May 09, 2019

Prosthetic Aortic Valves: Challenges and Solutions.

Prosthetic Aortic Valves: Challenges and Solutions.

Journal: Frontiers in cardiovascular medicine

Published: February 03, 2018

Correction: Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.

Correction: Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.

Journal: The Journal of experimental medicine

Published: March 12, 2017

Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.

Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.

Journal: The Journal of experimental medicine

Published: December 08, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026